Implementing a Nurse-Driven Protocol for Pneumococcal Vaccination in an Academic Rheumatology Clinic
Authors' conclusion
It is feasible to employ a nurse-driven protocol for improving pneumococcal vaccination rates in immunosuppressed patients, despite difficulties posed by coronavirus disease 2019 (COVID-19) pandemic disruptions.
Study context
- Population
- Immunosuppressed patients aged 19 to 64 years in an academic rheumatology clinic
- Comparison
- Postintervention vs baseline pneumococcal vaccination rates
- Outcome
- Monthly PCV13 or PPSV23 vaccination rate and proportion fully vaccinated (both PCV13 and PPSV23); aim: increase by ≥ 10%
- Follow-up
- 2-year period
Methodological detailsnurse-driven standing medical order, pre-post comparison, single academic rheumatology clinic
- Nurse-driven standing medical order
- Pre-post comparison
- Single academic rheumatology clinic
Main finding
As reported in the abstract
Average monthly vaccination rate with either PCV13 or PPSV23
Further findings
Proportion fully vaccinated (PCV13 and PPSV23)
Proportion fully vaccinated (pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23))
- Change statistically significant
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Implementing a Nurse-Driven Protocol for Pneumococcal Vaccination in an Academic Rheumatology Clinic. J Rheumatol. Published 1 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →